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ABSTRACT The membrane-proximal segment connecting the helical core with the transmembrane anchor of human
immunodeﬁciency virus type 1 gp41 is accessible to broadly neutralizing antibodies and plays a crucial role in fusion activity.
New predictive approaches including computation of interfacial afﬁnity and the corresponding hydrophobic moments suggest
that this region is functionally segmented into two consecutive subdomains: one amphipathic at the N-terminal side and one
fully interfacial at the C-terminus. The N-terminal subdomain would extend a-helices from the preceding carboxy-terminal
heptad repeat and provide, at the same time, a hydrophobic-at-interface surface. Experiments were performed to compare
a wild-type representing pretransmembrane peptide with a nonamphipathic defective sequence, which otherwise conserved
interfacial hydrophobicity at the carboxy-subdomain. Results conﬁrmed that both penetrated equally well into lipid monolayers
and both were able to partition into membrane interfaces. However only the functional sequence: 1), adopted helical structures
in solution and in membranes; 2), formed homo-oligomers in solution and membranes; and 3), inhibited gp41-induced cell-cell
fusion. These data support two roles for gp41 aromatic-rich pretransmembrane sequence: 1), oligomerization of gp41; and 2),
immersion into the viral membrane interface. Accessibility to membrane interfaces and subsequent adoption of the low-energy
structure may augment helical bundle formation and perhaps be related to a concomitant loss of immunoreactivity. These
results may have implications in the development of HIV-1 fusion inhibitors and vaccines.
INTRODUCTION
HIV-1 relies on the fusogenic activity of the gp120/41
envelope protein to introduce its genetic material into target
cells, thereby initiating the infectious cycle (reviewed in
Doms and Moore, 2000; Eckert and Kim, 2001). In the
currently accepted model, HIV-1 fusion cascade begins with
the binding of surface subunit gp120 to target cell receptors.
Activation causes the gp41 ectodomain to undergo structural
rearrangements toward a ﬁnal structure that has been
crystallographically solved (Chan et al., 1997; Weissenhorn
et al., 1997). These include the formation and/or reorienta-
tion of a triple-stranded a-helical coiled coil by the am-
ino-terminal heptad repeat domain (HR1). The resulting
intermediate ﬁlamentous structure is postulated to be simul-
taneously anchored to viral and target cell membranes,
through the transmembrane domain (TMD) and the fusion
peptide (FP), respectively. This structure collapses into
a folded-in-half six-helix bundle. In this trimeric hairpinlike
structure the carboxy-terminal helices (HR2) pack in the
reverse direction against hydrophobic grooves outside the
coiled coil, so that the amino- and carboxy-termini are placed
at the same end of the molecule. It is thus inferred that the
production of the trimeric hairpin might bring membranes
into close apposition.
It has been argued that the free energy released by the
formation of the helical bundle (estimated to be in the order
of 40–60 kT; Melikyan et al., 2000) would sufﬁce to induce
membrane fusion (in the order of several tens of kT for
the activation energy of hemifusion intermediate formation;
see an overview in Lentz et al., 2002). However, it is not
straightforward how conformational rearrangements in gp41
would couple mechanistically with the actual membrane
merger. In particular, bundle structures determined by x-ray
crystallography do not include the pretransmembrane
(preTM) sequences linking the HR2 to membrane-embedded
anchors (Chan et al., 1997; Weissenhorn et al., 1997). The
gp41 preTM linker comprises ;20 amino acids (residues
664–683 of the HIV-1 gp160 precursor). Based on the
protease sensitivity of the preTM segment, it has been
proposed that this region is a ﬂexible, structurally irregular
linker (Weissenhorn et al., 1997). However, if fully
extended, preTM sequence might keep the six-helix bundle
70 A˚ apart from the viral membrane (Fig. 1), i.e., distant
from the close contacting dehydrated areas required for
membrane fusion initiation.
The gp41 membrane-proximal region is accessible to anti-
gp41 broadly neutralizing mAbs such as 2F5, 4E10, and Z13
(Zwick et al., 2001). The antigenic nature of the region is
most likely conformationally constrained and varies along
the HIV-1 fusion pathway (Sattentau et al., 1995; Gorny and
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Zolla-Pazner, 2000; Zwick et al., 2001; Parker et al., 2001;
Finnegan et al., 2002). Mutational and biophysical analyses
have demonstrated that the preTM sequence is instrumental
in gp41-mediated fusion (Salzwedel et al., 1999; Mun˜oz-
Barroso et al., 1999; Sua´rez et al., 2000a,b). This sequence
partitions into membrane interfaces, aggregates within, and
eventually perturbs the bilayer architecture (Sua´rez et al.,
2000a,b; Sae´z-Cirio´n et al., 2002). NMR spectroscopy
detects formation of a well-deﬁned helical structure for
monomers in dodecylphosphocholine micelles; therefore an
interfacial location with the main axis parallel to the mem-
brane plane has been proposed (Schibli et al., 2001).
Despite these ﬁndings, the structural basis of the
functional and immunogenic properties of preTM is not
understood as yet. We have employed a new approach to the
problem by performing the computation of the gp41 preTM
hydrophobic-at-interface moment. This parameter indicates
that a preTM amphipathic helical segment could segregate
Trp residues and sustain protein-protein and protein-
membrane interactions. With the aim of testing this
prediction, experiments have been conducted in which we
compare the ability of preTM and related sequences to form
oligomers and interact with membranes. The results reported
in this work sustain the notion that gp41 preTM regions play
fundamental structural and functional roles and, as such,
represent important targets for the rational development of
antiviral therapies.
MATERIALS AND METHODS
Materials
1-Palmitoyl-2-oleoylphosphatidylcholine (POPC) was purchased from
Avanti Polar Lipids (Birmingham, AL). Calcein AM and CMAC
(CellTracker Blue) were from Molecular Probes (Junction City, OR).
Bis[sulfosuccinimidyl]suberate (BS3) was from Pierce (Rockford, IL). D2O,
octaethyleneglycol monododecyl ether (C12E8), N-acetyl-L-tryptophana-
mide (NATA), and Triton X-100 were obtained from Sigma (St. Louis,
MO). All other reagents were of analytical grade. The sequences,
DKWASLWNWFNITNWLWYIK (HIVc) representing the preTM stretch
of HIV-1 (BH10 isolate) gp41, its ﬂuorescent derivative (Rho-HIVc) labeled
with rhodamine at its N-terminus, and DKAASLANAFNITNWLWYIK
(HIVW(1–3)A) sequence representing a defective gp41 phenotype (Salzwedel
et al., 1999), were synthesized as their C-terminal carboxamides and puriﬁed
(estimated homogeneity[90%) at the Synthesis Facility of the University
Pompeu-Fabra (Barcelona, Spain). Peptide stock solutions were prepared in
dimethylsulfoxide (DMSO) (spectroscopy grade).
Hydrophobic moment calculations
To compute the hydrophobic-at-interface moment, we considered the
membrane interface-to-water (DGiwu) transfer free energies for each amino
acid (Wimley andWhite, 1996) as the moduli of the vectors that project from
the main axis of the secondary structure element following the direction of
the amino acid side chains (Sa´ez-Cirio´n et al., 2003). The hydrophobic
moment (mH) of a sequence of N residues was then calculated as the addition
of the N hydrophobicity vectors corresponding to the constituent amino
acids, following the equation (Eisenberg et al., 1982, 1984):
mH ¼ +
N
n¼1
Hn sinðdnÞ
 2
1 +
N
n¼1
Hn cosðdnÞ
 2 !1=2
; (1)
where Hn is the hydrophobicity of the n residue, and d is the angle formed
between side chains of consecutive residues, i.e., 1008 for helical
conformations.
Preparation of vesicles
Large unilamellar vesicles (LUV) were prepared following the extrusion
method of Hope et al. (1985) in 5 mMHepes, 100 mMNaCl (pH 7.4) buffer.
Lipid concentrations of liposome suspensions were determined by phos-
phate analysis (Bo¨ttcher et al., 1961). Mean diameter of vesicles was esti-
mated to be in the range of 100–110 nm by quasielastic light scattering using
a Malvern Zeta-Sizer instrument.
Secondary structure determination
Infrared spectroscopy (IR) measurements were conducted essentially as
described in Pereira et al. (1997). Samples consisted of ﬂoated peptide-lipid
complexes obtained in D2O buffer after ultracentrifugation. Solvent samples
FIGURE 1 (A) Diagram of structural components in HIV-1 gp41
ectodomain and their relative lengths. HR1, HR2, TMD, and the preTM
connecting HR2 with TMD have been drawn approximately to scale. Boxes
correspond to helical elements and the preTM is displayed as a fully
extended chain. Amino acid composition of the preTM sequence comprising
residues 664–683 of HIV-1 gp160 precursor is also shown. (B) Analysis of
interfacial afﬁnity distribution in mutant preTM regions and its correlation
with fusogenicity (number of syncytia in the ﬁeld relative to wild type in
parentheses) according to Salzwedel et al. (1999) (notation used to designate
mutants derived from same reference). Hydropathy-at-interface plots
(window ¼ ﬁve amino acids) corresponding to residues 661–709 of
gp160 precursor (BH10 isolate) were produced as described previously
(White andWimley, 1999; Sua´rez et al., 2000a) and aligned along invariable
TMD sequences. Peaks above the 0 level (horizontal line) correspond to
positive bilayer-to-water transfer free energy values.
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were also obtained from the fraction not containing lipid or peptide and
subsequently used as background controls. Infrared spectra were recorded in
a Nicolet 520 spectrometer equipped with an MCT detector. Samples were
placed between two CaF2 windows separated by 50-mm spacers. A total of
1000 scans (sample) and 1000 scans (reference) were taken for each
spectrum, using a shuttle device. Spectra were transferred to a computer
where solvent subtraction and band-position determinations were performed
as previously reported (Arrondo et al., 1993).
Monolayer penetration
Surface pressure was determined in a ﬁxed-area circular trough (mTrough
S system, Kibron, Helsinki). Measurements were carried out at room
temperature and under constant stirring. The aqueous phase consisted of 1
ml 5 mM Hepes, 100 mM NaCl (pH 7.4). POPC, dissolved in chloroform,
was spread over the surface and the desired initial surface pressure (p0) was
attained by changing the amount of lipid applied to the air-water interface.
Peptide was injected into the subphase with a Hamilton microsyringe. At the
concentrations used, peptides alone induced negligible increases in surface
pressure at the air-water interface.
Partitioning into membranes
Peptide partitioning into membranes was evaluated using POPC LUV
(Wimley and White, 1996) by monitoring the change in emitted Trp
ﬂuorescence. Corrected spectra were recorded in a Perkin Elmer MPF-66
spectroﬂuorimeter with excitation set at 280 nm and 5-nm slits. Partitioning
curves were subsequently computed from the fractional changes in emitted
Trp ﬂuorescence when titrated with increasing lipid concentrations. The
signal was further corrected for dilution and inner ﬁlter effects as described
in White et al. (1998) using the soluble Trp analog, NATA, which does not
partition into membranes. The apparent mole fraction partition coefﬁcients,
Kx(app), were determined ﬁtting the experimental values to an hyperbolic
function:
F=F0 ¼ 11 ½ðFmax=F0Þ  1½L
K1 ½L ; (2)
where [L] is the lipid concentration and K is the lipid concentration at which
the bound peptide fraction is 0.5. Therefore, Kx(app) ¼ [W]/K where [W] is
the molar concentration of water.
Peptide oligomerization
Clustering of HIVc peptide was monitored by the self-quenching effect
produced in aggregates of Rho-labeled peptide as described in Ben-Efraim
et al. (1999) and Sae´z-Cirio´n et al. (2002). Changes in ﬂuorescence intensity
were measured at 581 nm (5-nm slit) with excitation set at 550 nm (5-nm
slit). Maximal dequenching (or 0% quenching) was inferred from samples
solubilized with Triton X-100 (0.5% v/v). Occasionally, maximal de-
quenching measurements were carried out in SDS-solubilized samples,
always with good correlation. Oligomerization was also evaluated using
Tricine-SDS-PAGE. Samples consisted of 45 mg peptide incubated in
presence or absence of 20 mM BS3 bifunctional cross-linking reagent
(Knoller et al., 1991). Cross-linked complexes were subjected to gel
electrophoresis. Gels were stained with Gelcode blue stain reagent (Pierce,
Rockford, IL).
Cell-cell fusion assays
TF228.1.16 cells expressing HIV-1 Env (BH10 strain, a gift from Dr. Z.
Jonak, SmithKline Beecham) and HeLaT41 cells expressing CD4 and
CXCR4 (obtained from AIDS Research and Reference Reagent Program,
NIH) were maintained as described in Melikyan et al. (2000). TF228.1.16
cells (referred to as effector cells) were loaded with ﬂuorescent dye calcein
AM (green emission). The target (HeLaT41) cells were loaded with CMAC
(blue emission). Fusion was quantiﬁed by ﬂuorescence microscopy by
measuring the fraction of cells positive for both dyes out of the total number
of effector/target cells in contact, as described in Melikyan et al. (2000).
Brieﬂy, effector and target cells were mixed in the presence or in absence of
HIVc or HIVW(1–3)A peptides, allowed to settle on polylysine-coated eight-
well chambered slides, and incubated at 378C for 2 h. Images of calcein and
CMAC ﬂuorescence were acquired by intensiﬁed charge-coupled device
(CCD) camera using appropriate ﬁlter sets, digitized, pseudocolored, and
overlaid on each other to facilitate detection of cell fusion.
RESULTS
Interfacial hydrophobicity distribution in gp41
preTM sequence
As shown in Fig. 1 A, the gp41 membrane-proximal domain,
or pretransmembrane sequence, is located between the
carboxy-terminal helix (residues 624–665 of HIV-1 Env
precursor) and the transmembrane region (residues 684–706
of HIV-1 Env precursor). In a compelling site-directed mu-
tagenesis analysis of the preTM region, Salzwedel and co-
workers (Salzwedel et al., 1999) described the production
and functional characterization of 25 gp41 variants. Among
these variants, mutants displayed in Fig. 1 B were selected
based on the following criteria. We analyzed the deletions
and substitutions reported by these authors (full deletion and
insertions of epitopes were not analyzed) and established the
relationship existing between the capacity of a particular
preTM sequence to partition into the membrane interface
(Wimley and White, 1996) and the fusogenic activity of
gp41 (Salzwedel et al., 1999). When we plot the fusion index
versus DG for transfer from membranes into water (data not
shown), it follows that the wild-type (wt) sequence is the
most active, in accord with its largest DG value, whose
magnitude is linearly related to the fusion index for most
substitutions. However, for the group of mutants displayed
in Fig. 1 B, the fusion index is much lower. Thus, these
sequences showed comparable capability to partition into
membranes to that shown by corresponding functional
sequences but displayed defective fusion phenotypes. This
suggested that, in addition of the overall value, the actual
distribution of hydrophobicity (i.e., a structure-related factor)
might affect the function of this sequence.
The interfacial hydropathy plots displayed in Fig. 1 B
indeed suggest the existence within gp41 preTM of two
positive peaks, each comprising ;10 amino acids. Since
helical anchors immersed into one monolayer interface
might be shorter than TMD anchors (Picot et al., 1994), we
calculated average hydrophobicity-at-interface in the plots
using small ﬁve amino acid windows. Deletions in the
preTM region correlated with ablation or merging of the two
peaks, and concomitant loss of function. Likewise, the
analysis of the triple substitutions and scrambled SC7 mutant
suggested that the presence of both peaks might promote
fusogenicity. Thus results displayed in Fig. 1 B suggest that
gp41 preTM region contains two interfacial segments,
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a pattern recently described to occur also in 6K, the alpha-
virus protein involved in catalyzing membrane ﬁssion during
viral budding (Sanz et al., 2003). An interfacial sequence
containing two hydrophobic-at-interface segments also
exists in vesicular stomatitis virus (VSV) glycoprotein mem-
brane-proximal region (data not shown), which is also
involved in fusion and budding processes (Robinson and
Whitt, 2000; Jeetendra et al., 2002).
The N-terminal gp41 preTM subdomain (peak 1 in Fig.
1 B) would also generate a face with strong afﬁnity for
membranes, if folded into an a-helix (Fig. 2). Hydrophobic
moments measure the periodicity of residue distribution
along the secondary structure elements (Eisenberg et al.,
1982, 1984). Preferential orientation of the hydrophobic
residues toward one face of the structure element has been
proposed to favor hydrophobic interactions between protein
structural components and between membranes and protein
sequences. Considering that preTM may be part of the
soluble gp41 ectodomain (see Discussion), its hydrophobic
moment was computed using the membrane interface-to-
water transfer free energies (DGiwu) for each amino acid
(Wimley and White, 1996; White and Wimley, 1999) as the
moduli of the vectors that project following the direction of
the amino acid side chains. It must be noted that, when
partition from water into interfaces of whole residues is taken
into consideration, the relative amino acid hydrophobicities
seem to be different from those derived from bulk-phase
partitioning of side chains (see for extensive discussions
Deber and Goto, 1996; White and Wimley, 1999; Nieva and
Sua´rez, 2000). For instance, nonpolar Val and Ala residues,
commonly present in TMD sequences, would not promote
partitioning into membranes, whereas aromatic Trp, Tyr, and
Phe residues would be efﬁcient promoters. This difference
also affects the hydrophobic moment calculation (Fig. 2).
According to plots in Fig. 2 A, a helical sequence that
segregates residues to enable maximal partitioning from
water into membranes would be barely detected as am-
phipathic using Eisenberg hydropathy scale.
FIGURE 2 Hydrophobic moments (as a function of the
d angle) calculated according to different hydropathy
scales. (A) Comparison using WW hydrophobicity-at-
interface (left panel) or Eisenberg hydrophobicity (right
panel). The selected sequences WWEEWEEWWEEWEE
(solid lines) and IIRRIRRIIRRIRR (dotted lines) contain,
alternating with helical periodicity, most hydrophobic and
most hydrophilic residues in WW and Eisenberg scales,
respectively. (B) Hydrophobic moment of the HIV-1
gp160 664–674 segment (;3 helical turns) calculated as
a function of the d angle. Sequences derived from wild-
type (solid lines) and W(1–3)A mutant (dotted lines)
proteins are compared using three different hydrophobicity
scales (WW, Eisenberg, and KD). Dashed line in WW
panel corresponds to the 673–683 gp160 stretch.
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Plots in Fig. 2 B show the calculated WW moments as
a function of the angle between residues (d). The plot for
the amino-terminal preTM segment ( peak 1 in Fig. 1 B)
displayed a maximum at;1008, indicating that the adoption
of an a-helical conformation generates a Trp-rich surface,
whereas the carboxy end ( peak 2 in Fig. 1 B) seemed not to
be amphipathic. The W(1–3)A triple substitutions within
HIV-1 gp41 abrogate its ability to promote cell-cell fusion
and virus entry without affecting maturation, transport, or
CD4-binding ability of the protein (Salzwedel et al., 1999).
These triple Ala substitutions induced the disappearance of
the helical interfacial peak of the preTM region. Accord-
ingly, the W(1–3)A mutant also showed a largely reduced
moment at d ¼ 1008 (top panel in Fig. 2 B). A difference
between wt and mutant sequences was not evident when
Eisenberg or KD hydropathy scales were applied to calculate
the hydrophobic moment (bottom panels in Fig. 2 B).
In agreement with the previous observations, the sum of
moments with ﬁxed d ¼ 1008 in ﬁve-residue windows
detected a peak comprising 10 amino acids (residues 663–
672 of HIV-1 gp160) at the N-terminus of HIV-1 gp41
preTM (Fig. 3). As shown in Fig. 3, an amphipathic helical
motif was present in different HIV-1 isolates and in other
lentiviruses. This suggests that the N-terminal segment of
gp41 preTM may become an extension of the preceding
helical HR2 segment of gp41 ectodomain. This helical HR2
extension shows a tendency to partition into membrane
interfaces and is segregated from its C-terminal segment that
directly links preTM to the TMD.
IR analysis of gp41 preTM structure in solution
and membranes
The structural changes induced by W(1–3)A substitutions
were investigated in solution (Fig. 4 A) and membranes (Fig.
4 B) by looking at the infrared amide I band located between
1700 and 1600 cm1 (Arrondo and Gon˜i, 1998, 1999).
Deconvolved spectra of HIVc and HIVW(1–3)A peptides are
shown. For HIVc (top spectra) the presence of lipids
produces shifts of the 1650 cm1 and the 1629 cm1 com-
ponents to 1654 cm1 and 1635 cm1, respectively. On the
other hand, in HIVW(1–3)A (bottom spectra), the 1626 cm
1
band is shifted to 1621 cm1 and two other components at
1644 and 1656 cm1 are present in the presence of lipids.
The main component in solution is at 1650 cm1 for HIVc,
whereas it is at 1626 cm1 for HIVW(1–3)A.
The band at 1650 cm1 (60% of total area of HIVc
in solution) can be unambiguously assigned to a canonical
a-helix. Assignment of component at 1629 cm1 (30% of
total area) is not straightforward. Bands below 1635 cm1
together with high frequency components are usually
assigned to b-sheet in proteins. However, in oligopeptides
short a-helices have been found to display a band around
1635 cm1 (Martinez and Millhauser, 1995); and using 13C-
labeled peptides it has been shown that a-helices with a
solvated backbone also give rise to signals in that range of
wave numbers. Besides, helix-helix interactions in coiled
coils also exhibit bands in the region usually attributed to
b-sheet (Reisdorf and Krimm, 1996), because of the cross-
hydrogen bonds that can be formed. These cross-hydrogen
bonds have been described in bacteriorhodopsin (Ubarret-
xena-Belandia and Engelman, 2001) that also exhibits an
anomalous infrared spectrum (Rothschild and Clark, 1979).
The presence of lipids produces comparable shifts in both
components (to 1654 and 1635 cm1, respectively) but does
not signiﬁcantly alter the overall structure (55 and 36% of
total area, respectively). The former effect can be interpreted
either as changes in the geometry of the structural element, or
a shift from aqueous to a less polar environment with less
strong hydrogen bonds.
To explore further the origin of the 1635 cm1 band, we
analyzed IR spectra of HIVc helices in a membrane milieu.
Fluorescence data indicated that rhodamine-labeled HIVc in
lipid vesicles displays a dose-dependent tendency to self-
associate (Sa´ez-Cirio´n et al., 2002). This is illustrated by
results obtained in POPC LUV containing increasing pep-
tide loads (Fig. 5 A). Since detergent-solubilized HIVc is
monomeric as judged by SDS-PAGE (see Fig. 7 A), Rho-
HIVc ﬂuorescence quenching levels reﬂect different self-
FIGURE 3 Hydrophobic-at-interface moments (sum of the moments in
a window of length 11 amino acids) for a ﬁxed d ¼ 1008 corresponding to
preTM-TMD regions derived from different HIV-1 isolates and other
lentiviruses. The plotted stretch comprises residues 661–709 of gp160
precursor or homologous sequences in other proteins.
Structure-Function of Pretransmembrane 3773
Biophysical Journal 85(6) 3769–3780
association degrees at the membrane surface. Thus these
modelmembranes provide a tool to assess helical structures as
both monomers or multimers. In HIVc, decreasing the
peptide/lipid ratio from 1:50 to 1:1000, where the peptide
is most likely monomeric (Fig. 5 A), results in a more sym-
metrical band at 1653 cm1 (Fig. 5 B), with no contribution
from the component around 1635 cm1, thus reinforcing the
assignment of this band to helix-helix contacts in our system.
At the 1:50 ratio where self-association is prominent (Fig.
5 A), the a-helical band splits into two components, absorb-
ing at 1656 and 1649 cm1, besides the presence of a band at
1639 cm1, as was postulated previously for coiled coils
(Reisdorf andKrimm, 1996). The 1:250 peptide/lipid ratio ex-
hibits an intermediate pattern, but is dominated by the band
attributed to canonical a-helix at 1653 cm1.
The structure of HIVW(1–3)A in solution differs from that
of HIVc (Fig. 4 A). It has its most intense band at 1626 cm
1
(47% of total area), indicating an extended conformation of
the peptide. Moreover, in the case of this mutant, peptide-
lipid binding produces the opposite effect. Rather than
keeping a structural organization, the shift downwards to
1621 cm1 of the major component (40% of total area),
points to a more massive aggregation of the peptide in
membranes. The smaller components at 1644 cm1 (35%)
and 1656 cm1 (25%) would indicate the presence of
unordered structure and b-turns respectively, as has been
shown in all-b proteins such as lectins (Chehin et al., 1999).
In conclusion, the wild-type sequence seems to self-
associate into helical multimers both in solution and in
membranes. In addition, the effect of lipids on both peptides
are quite contrasting. Whereas the main conformation of
HIVc is not affected upon its insertion in the lipid bilayer
maintaining the solution secondary structure, HIVW(1–3)A
stability is disturbed by the presence of lipids, resulting in
aggregation-denaturation of the mutant peptide. This con-
FIGURE 4 Fourier self-deconvolved infrared spectra of HIVc and
HIVW(1–3)A in the amide I region. IR spectra of the peptides were measured
in D2O buffer (A) and associated to POPC LUV (B). To obtain the latter
samples, peptides and vesicles were incubated at 1:250 peptide/lipid mole
ratio and lipid-bound peptide was subsequently isolated by ﬂotation in D2O
buffer as previously described (Pereira et al., 1997).
FIGURE 5 (A) Self-association of Rho-HIVc in POPC membranes.
Peptide was incubated with POPC vesicles at the indicated peptide/lipid
mole ratios (Ri) and the percentage of quenching calculated as previously
described (Sa´ez-Cirio´n et al., 2002). The quenching levels attained in
membranes were independent of the method used to obtain lipid-peptide
mixtures, i.e., using either ﬁxed lipid or ﬁxed peptide concentrations.
Calculated percentages are mean values 6 SE of four independent
determinations. Arrows indicate the Ris selected for IR characterization.
(B) Fourier self-deconvolved infrared spectra of HIVc incorporated into
POPC membranes. The peptide was added to LUV at the indicated Ris,
under the experimental conditions used in the previous panel. Lipid-peptide
complexes were subsequently isolated from the ﬂoating fractions after
ultracentrifugation in D2O buffer. The spectra are not drawn to the same
scale to better show the 1680–1620 amide I region.
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ﬁrms the predictions in Figs. 2 and 3 and highlights the
speciﬁc role of Trp residues in stabilizing the sequence
folding also in solution.
Gp41 preTM interaction with membranes
The ability of HIVc and HIVW(1–3)A peptides to penetrate
membrane bilayers was ﬁrst studied by the monolayer
technique (Fig. 6 A). The penetration capacity depending on
the monolayer surface pressure may be inferred from the
monolayer exclusion pressure value (pex), or initial pressure
(p0) at which no increment in pressure is observed after
injection of the peptide into the subphase (Dp ¼ 0). The pex
values obtained from plots in Fig. 6 Awere 37.2 mNm1 and
34.2 mN m1 for HIVc and HIVW(1–3)A, respectively. Both
values are within the range of lateral pressures postulated to
arise from the lipid packing density that exists in natural
membranes and unstrained bilayers (p0 $ 30 mN m
1;
Marsh, 1996).
Consistent with these observations both HIVc and
HIVW(1–3)A were also able to penetrate efﬁciently lipid
bilayers of POPC LUV (Fig. 6, B and C). Results in Fig. 6 B
demonstrate that the intrinsic ﬂuorescence of both peptides
increased in the presence of these vesicles (dotted versus
solid lines). This is indicative of the Trp residues sensing
a low-polarity environment of the lipid bilayer. However,
due to the higher Trp content, a higher tendency for HIVc to
spontaneously transfer from water into membranes is ex-
pected (Wimley and White, 1996). In accordance with the
predictions, titration of the peptides in solution with increas-
ing amounts of lipid vesicles (Fig. 6C) demonstrated a higher
apparent partitioning capacity for the wt-representing pep-
tide, (Kx(app)[10
7), compared to the mutant, (Kx(app) 106).
The comparable saturation levels observed for both peptides
also suggest that membrane-associated species are probably
sensing a similar membrane, low-polarity environment.
Taken together these data demonstrate that the W(1–3)A
mutation did not signiﬁcantly affect the capacity of the
preTM to insert into membranes upon binding (Fig. 6, A and
B) but reduced its afﬁnity for the interface (Fig. 6 C).
Gp41 preTM self-association in solution
Experiments were conducted to explore homo-oligomeriza-
tion of the HIVc sequence. As shown in Fig. 7 A, HIVc
showed a single band on SDS-PAGE with a molecular
weight corresponding to that of a monomer (2600 Da).
This is consistent with the capacity of the detergent to
solubilize Rho-HIVc peptide oligomers. After subjecting the
peptide to chemical cross-linking, oligomers became appar-
ent on the gel. The cross-linking reaction developed similarly
when the reagent was present at time ¼ 0, or when added
FIGURE 6 Interaction of HIVc (open circles) and HIVW(1–3)A ( ﬁlled
circles) with membranes. (A) Penetration of the peptides into POPC
monolayers. The maximal increase in surface pressure produced upon
injection of peptide in the subphase has been plotted as a function of the
initial pressure of the phospholipid monolayer. The dotted line begins at 30
mN/m. (B) Fluorescence emission spectra in buffer (continuous lines) and
incubated with POPC LUV (dotted lines). Peptide concentration was 0.5
mM and, in vesicle samples, the peptide/lipid ratio was 1:200. (C)
Partitioning into membranes. Curves were estimated from the fractional
change in Trp ﬂuorescence in the presence of increasing amounts of POPC
LUV. The solid lines correspond to the best ﬁts of the experimental values to
Eq. 2.
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after 90 min of preincubation of the peptide in solution.
These oligomers were not observed in the case of HIVW(1–
3)A peptide. In summary, the SDS-PAGE analysis suggests
the formation of HIVc homo-oligomers in solution.
This self-association process of HIVc in solution was
subsequently studied using the ﬂuorescently labeled Rho-
HIVc sequence (Fig. 7 B). When ﬂuorophore molecules are
in close proximity, rhodamine emission diminishes (Hoek-
stra et al., 1984; Ben-Efraim et al., 1999). Thus, Rho-
quenching efﬁciency correlates with the aggregation state of
the peptide (Ben-Efraim et al., 1999; Sa´ez-Cirio´n et al.,
2002). Experiments in Fig. 7 B show that Rho emission
decreased with time of incubation in solution (inset). When
a fraction of Rho-HIVc labeled peptide was replaced by
unlabeled HIVc peptide, Rho quenching was hampered
(compare bars a and b in Fig. 7 B). This is consistent with
the observed ﬂuorescence attenuation due to peptide self-
association.
Synthetic preTM peptide speciﬁcally inhibits
gp41-induced fusion
The ability of preTM to self-associate in solution and
membranes raised the possibility of preTM homo-oligomer
formation at some stage during gp41-induced fusion process.
To explore this hypothesis we tested whether the preTM
peptides could interfere with cell-cell fusion induced by
HIV-1 envelope (Fig. 8). Co-incubation of the effector and
target cells at 378C in the absence of peptides resulted in
extensive fusion, as evidenced by cytoplasmic content mix-
ing between cells. When HIVc was present in the external
solution, it inhibited fusion in a dose-dependent manner
showing an apparent IC50 value of 577 nM (Fig. 8, open
circles). In contrast, the mutant HIVW(1–3)A peptide did not
suppress fusion even at concentrations as high as 10 mM
( ﬁlled circles). In control experiments, neither of these two
peptides inhibited inﬂuenza hemagglutinin (HA)-mediated
fusion between HA-expressing cells and red blood cells (data
not shown). This implies that the inhibitory effect of wt
preTM peptide was through its interaction with HIV
envelope protein and not through its partitioning into cell
membranes and causing nonspeciﬁc perturbations. Neither
of the two peptides showed a lytic activity on the cells within
the concentration range tested here (data not shown).
FIGURE 7 Self-association of the gp41 preTM sequence in solution. (A)
Oligomerization of HIVc peptide. HIVc or HIVW(1–3)A were incubated alone
(lane 2) or in presence of 20 mMBS3 for 30 min, added before (lane 3), or 90
min after the peptide (lane 4). Samples were prepared for SDS-PAGE and
resolved on 16.5% Tris-tricine polyacrylamide gels. In the ﬁrst lane, the
molecular weight (kD) markers were run as indicated. (B) Clustering of Rho-
HIVc in solution. Rho emission intensity (lex ¼ 550 and lem ¼ 581) was
measured 150 s after peptide injection (2-mM ﬁnal concentration) into
buffer. To investigate the effect of replacing Rho-HIVc with unlabeled HIVc,
Rho-HIVc:HIVc mixtures were incubated at a 1:19 molar ratio. For
comparison all intensity values were normalized relative to maximal signal
in detergent-solubilized samples. The calculated values of Rho emission
values are mean values 6 SE of four independent determinations. (a) Rho-
HIVc:HIVc, 1:19; (b) Rho-HIVc. (Inset) Time records (four traces per
sample) of Rho emission ﬂuorescence in the different samples.
FIGURE 8 Inhibition of HIV Env-induced cell-cell fusion by HIVc (open
circles) and HIVW(1–3)A (ﬁlled circles) peptides. The indicated concen-
trations of either wt- or mutant-like peptides were added to the mixture of the
Env-expressing and CD41/CXCR41 HeLaT41 target cells. Cells were
incubated for 2 h at 378C, and the extent of fusion was determined in at least
four independent experiments, as described in Materials and Methods. Bars
are SE of mean.
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DISCUSSION
PreTM role in membrane anchoring
Truncation of the gp41 carboxy terminus beyond Lys683
(i.e., last residue of the preTM region) causes loss of
membrane anchoring and secretion of the glycoprotein in
a soluble form (Dubay et al., 1992; Owens et al., 1994;
Salzwedel et al., 1999). This might be interpreted as an
indication that the preTM sequence is not sufﬁcient to
membrane anchor gp41 with a deleted TMD. However, an
inspection of the energetics of helix insertion suggests that
a single preTM region might potentially function as a stable
interfacial anchor. Estimations of the free energy of insert-
ing the a-helical preTM region (residues 664–683) into
membranes as proposed by White and co-workers (White
et al., 2001) predicts a low-energy interfacial location, DGins
 16 kcal mol1, rather than a transmembrane topology,
DGins  5 kcal mol1. These values may be compared to
the energy cost of gp41 TMD (residues 684–706) insertion
into membranes:  9 kcal mol1, i.e., a value close to that
measured for stably inserted glycophorin A TMD (White
et al., 2001). Thus, at least in theory, the preTM could anchor
the gp41 ectodomain to membranes more stably than does
the TMD.
These estimations support the notion that in the mature
prefusogenic gp41, the membrane proximal region must be
initially folded as a soluble element that becomes membrane
bound only after HIV-1 Env activation (Zwick et al., 2001).
They also suggest that, in addition to the six-helix bundle,
the eventual low-energy state of the protein might comprise
a membrane-proximal region immersed into the membrane
interface. The fact that preTM region has been shown to bind
cholesterol in the context of the full-length envelope protein
(Vincent et al., 2002) gives support to this hypothesis.
Importantly, recent hydrophobic photolabeling studies have
revealed fusion-dependent incorporation of a label into the
transmembrane domain and membrane-proximal region of
HR2 (Raviv et al., 2003), suggesting the existence after
fusion of a membrane-embedded preTM structure connect-
ing both gp41 elements.
PreTM role in oligomerization
One possible means to enhance preTM solubility within the
prefusogenic gp41 intermediate is to cluster interfacial
residues into an occluded surface. This might be achieved
through oligomerization of amphipathic helices. Our hy-
drophobicity-at-interface distribution analysis suggests that
the functional preTM sequence is segmented into two sub-
domains: one amphipathic at the N-terminal side and one
interfacial at the C-terminus (Figs. 1–3). This supports
a supplementary role for the preTM sequence in sustaining
the prefusogenic gp41 oligomeric organization existing in
the virion (Center et al., 2002). However, we caution that
membrane partitioning does not seem to be signiﬁcantly
affected by the tendency of preTM peptides to self-associate
in solution. We have not observed differences in partitioning
at peptide concentrations ranging from 0.1 to 1 mM, and the
kinetics of incorporation into membranes of Rho-labeled
sequences were similar at 0.1 and 4 mM (i.e., 40 times more
concentrated; data not shown). Moreover, the C-terminal
segment (residues 674–683 of gp160) contributes enough
partitioning energy to enable association with and penetra-
tion into membranes, even of denatured sequences (Fig. 6).
Thus, partial preTM amphipathicity may potentially contrib-
ute to gp41 prefusion structure stability and solubility, but
additional factorsmust exist that precludemembrane exposure
of this region before fusion activation.
At any rate, the amphipathic-at-interface N-terminal
stretch (residues 664–673) seems to preserve an overall
a-helical structure in solution and in membranes (Figs. 4
and 5). IR (Fig. 5) and NMR (Schibli et al., 2001) structural
data reveal amonomeric helical structure that would be preva-
lent in membranes at low doses. This structure self-associates
at higher membrane loads or in the presence of raft-type
lipids (Sa´ez-Cirio´n et al., 2002). Results in this work conﬁrm
that preTM may establish helix-helix interactions in solution
and in membranes (Figs. 4, 5, and 7).
As depicted in Fig. 9 A, the molecular model for the
elongation of HR2 including the preTM amino subdomain
shows that hydrophobic HR2 residues implied in packing
against the trimeric HR1 coiled coil, and aromatic-interfacial
residues might occupy opposite faces of an helix. Thus,
a putative oligomeric preTM structure might also help
preventing HR2 packing against trimeric HR1 coiled coil. In
fact, recent studies demonstrate that HR2 regions are
exposed and accessible to inhibitors in native and prefuso-
genic intermediates of gp41 (Root and Hamer, 2003;
Koshiba and Chan, 2003). This mechanism would also be
in agreement with the disappearance of mAb 2F5 binding
site upon HR1/HR2 complex formation (Gorny and Zolla-
Pazner, 2000). The epitope recognized by 2F5 mAb
comprises residues 656–671 (Parker et al., 2001), i.e., it
includes almost completely the amphipathic preTM amino
subdomain. This epitope is recognized at the native
prefusogenic form of gp41 and is thought to become
occluded upon fusion activation when the six-helix bundle
forms (Sattentau et al., 1995; Gorny and Zolla-Pazner, 2000;
Finnegan et al., 2002).
Thus, interfacial hydrophobicity could play a role by
eliciting the preTM-membrane interaction required to
release conformational constraints in HR2 and facilitate
HR1-HR2 interactions. Of note, a W(1–5)A mutant in
which the 5 Trps have been substituted with Alas induces
a defective fusion process arrested at the level of pore
opening (see below) (Mun˜oz-Barroso et al., 1999). This
mutant, for which we foresee a defect in preTM-membrane
association, is actually more susceptible to inhibition by
T20 (Mun˜oz-Barroso et al., 1999), indicating a defect in
bundle formation.
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PreTM role in fusion activity and inhibition
Different cell-cell fusion assays demonstrate that gp41
lacking preTM sequence is not fusogenic, i.e., it is incapa-
ble of mediating both membrane-and-volume mixing and
syncytium formation (Salzwedel et al., 1999; Mun˜oz-
Barroso et al., 1999). In contrast, several mutants, including
aforementioned W(1–5)A, SC7, and D678–682, are specif-
ically defective in syncitium formation or complete mixing
of cell contents (Mun˜oz-Barroso et al., 1999). The fusion
activity of W(1–5)A mutant, namely, the formation of non-
expanding small fusion pores, is similar to that exhibited
by GPI-linked hemagglutinin (GPI-HA) of inﬂuenza virus
(Markosyan et al., 2000). This mutation provokes the
elimination of positive hydrophobic-at-interface peaks from
preTM region (data not shown). Thus, it appears that in the
absence of interfacial hydrophobicity at the preTM region,
gp41 displays the activity of ectodomains, which are
membrane linked through lipidic tethers. Based on this
outcome and our results, we suggest two mutually non-
exclusive mechanisms according to which preTM interfacial
hydrophobicity could play a role at fusion-pore enlargement
(illustrated in Fig. 9, B and C):
Modulation of monolayer net curvature
Long interfacial preTM sequences seem to be functional in
fusion (Salzwedel et al., 1999; Mun˜oz-Barroso et al., 1999;
Sua´rez et al., 2000a; Jeetendra et al., 2002) and also in
membrane ﬁssion processes that take part during viral
budding (Robinson and Whitt, 2000; Sanz et al., 2003). A
low-energy interfacial topology would confer net positive
curvature to the preTM-containing membrane monolayer,
a factor that might help budding. Conversely, according to
the ‘‘stalk-pore’’ hypothesis of fusion, positive curvature in
contacting monolayers (cis-monolayers) would hinder the
formation of a ‘‘stalk’’ (an initial lipidic intermediate that
locally connects the cis-monolayers of two apposed
membranes) (Chernomordik et al., 1995; Siegel and Epand,
1997; Razinkov et al., 1998; Lentz et al., 2000, 2002). Thus,
in the framework of this theory, we have to infer that preTM
must insert into membranes at later stages of the process. For
instance, interfacial preTM structure might promote positive
curvature by expanding the cis-monolayer in trans-mono-
layer contacts (TMCs), a second lipidic intermediate in the
fusion pathway (Fig. 9 B). As a result, expansion of fractured
single-bilayer diaphragm in the TMC intermediate would be
favored (Siegel and Epand, 1997; Lentz et al., 2000). In this
way, preTM interfacial hydrophobicity would elicit the
eventual opening of fusion pores connecting the initially
separated aqueous environments.
Self-assembly of gp41 monomers in membrane surfaces
It has been postulated that an assembly of gp41 oligomers
could establish the molecular scaffold that enables mem-
branes to merge. As described by Markosyan et al. (2002),
recombinant bundles did not inhibit fusion. Thus, it is
unlikely that bundles interact with each other at the fusion
site. We propose that the preTM embedded in the viral
membrane interface is responsible for self-assembly of gp41
FIGURE 9 Putative roles of interfacial hydrophobicity at gp41 preTM
region. (A) Assembly of N-terminal amphipathic preTM region would
hinder HR1-HR2 interactions. (a) Helical model for HIV-1 gp160
652QQEKNEQELLELDKWASLWNWFNIT676 sequence (underlined
residues are part of the gp41 HR2 domain). Green side chains denote the
residues participating in hydrophobic packing with HR1 helices in the gp41
six-helix bundle crystal structure. Red side chains belong to hydrophobic-at-
interface residues of the N-terminal subdomain in the preTM. (b) Relative
orientation of residues participating in hydrophobic packing with HR1
helices (green) and hydrophobic-at-interface residues (red) in prefusion
(left) and postfusion structures (right). (B) Differential increase of monolayer
surface by interfacial preTM may help fusion pore opening. A fractured
TMC (a) might be brought to opened fusion pore (b) after hydrophobic-at-
interface preTM (red) insertion into cis-monolayers. (C) Formation of
fusion-competent gp41 complexes at the membrane surface. Fusion acti-
vation would lead to preTM insertion (a). Gp41 trimers (b, top view) would
assemble into fusion-competent arrangements stabilized through preTM
interactions (c, top view). Externally added HIVc would interfere with the
assembly of functional complexes in membranes (d, top view). PreTM, HR1,
and HR2 are designated in red, purple, and green, respectively.
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at the fusion site (see also Sa´ez-Cirio´n et al., 2002) and,
therefore, a deﬁned hydrophobicity distribution along the
sequence might condition the rate of formation and/or
eventual structure of gp41 complexes. The inhibition data
reported in this work (Fig. 8) are consistent with this
hypothesis. Our estimations indicate that 99% of the added
peptide partitions into membranes under the experimental
conditions used in cell-cell fusion experiments. Thus, a likely
mechanism of the inhibitory activity of the HIVc peptide is
through its binding to the gp41 cognate preTM region in its
membrane-bound state, thereby interfering with functional
oligomerization of HIV-1 Env (Fig. 9 C). This inhibition
mechanism would be reminiscent of that previously pro-
posed by Kliger et al. (2001) for the T20 peptide.
CONCLUSIONS
Unraveling gp41 preTM structure-function relationship was
instrumental in our design of inhibition of cell-cell fusion
and may implement anti-HIV drug and vaccine development
(Zwick et al., 2001). The hypothesis that stems from our
predictions (Figs. 1–3) is that the interfacial hydrophobicity
distribution might condition this element’s structure func-
tion, particularly its tendency to oligomerize as an a-helix in
solution and membranes. Experimental data generated so far,
including mutagenesis and biophysical characterizations, are
consistent with this hypothesis. However, we caution that
prefusogenic and postfusogenic gp41 atomic structures, inc-
luding the membrane-proximal region, are still unavailable.
Moreover, even if in the past biophysical characterization of
synthetic peptides representing different regions of the HIV-
1 gp41 subunit has led to fundamental conclusions on the
structural organization and putative mechanism of action of
this protein (Doms and Moore, 2000; Eckert and Kim, 2001),
we cannot rule out that the structure of these sequences might
turn out to be different within full-length gp41.
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